- Home
- VSTA vs IPHA Comparison
VSTA vs IPHA Comparison
Compare VSTA & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTA
- IPHA
- Stock Information
- Founded
- VSTA 1966
- IPHA 1999
- Country
- VSTA Brazil
- IPHA France
- Employees
- VSTA N/A
- IPHA N/A
- Industry
- VSTA Other Consumer Services
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- VSTA Real Estate
- IPHA Health Care
- Exchange
- VSTA Nasdaq
- IPHA Nasdaq
- Market Cap
- VSTA 187.6M
- IPHA 148.3M
- IPO Year
- VSTA 2020
- IPHA 2019
- Fundamental
- Price
- VSTA $2.43
- IPHA $1.69
- Analyst Decision
- VSTA Sell
- IPHA Strong Buy
- Analyst Count
- VSTA 2
- IPHA 1
- Target Price
- VSTA $3.00
- IPHA $11.50
- AVG Volume (30 Days)
- VSTA 241.6K
- IPHA 49.9K
- Earning Date
- VSTA 11-07-2024
- IPHA 09-12-2024
- Dividend Yield
- VSTA N/A
- IPHA N/A
- EPS Growth
- VSTA N/A
- IPHA N/A
- EPS
- VSTA N/A
- IPHA N/A
- Revenue
- VSTA $280,865,717.00
- IPHA $36,202,722.00
- Revenue This Year
- VSTA $12.97
- IPHA N/A
- Revenue Next Year
- VSTA $11.26
- IPHA $101.65
- P/E Ratio
- VSTA N/A
- IPHA N/A
- Revenue Growth
- VSTA 6.41
- IPHA N/A
- 52 Week Low
- VSTA $1.60
- IPHA $1.29
- 52 Week High
- VSTA $4.28
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- VSTA 56.19
- IPHA 42.95
- Support Level
- VSTA $2.12
- IPHA $1.60
- Resistance Level
- VSTA $2.44
- IPHA $1.87
- Average True Range (ATR)
- VSTA 0.16
- IPHA 0.13
- MACD
- VSTA 0.03
- IPHA -0.04
- Stochastic Oscillator
- VSTA 95.56
- IPHA 16.67
About VSTA Vasta Platform Limited
Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.